Loading clinical trials...
Loading clinical trials...
This is a Phase 1b, open-label, multicenter, safety, tolerability and efficacy study of HC-7366 in combination with belzutifan (WELIREG™). This is a multipart study that consists of a HC-7366 monother...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
HiberCell, Inc.
Collaborators
NCT07227402 · Renal Cell Carcinoma
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT04693377 · Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, and more
NCT07117227 · Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), and more
NCT05969496 · Renal Cancer, Kidney Cancer, and more
University of Arizona Cancer Center
Tucson, Arizona
University of California San Diego Moores Cancer Center
La Jolla, California
Cedars-Sinai Medical Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions